Access here alternative investment news about Glaxosmithkline To Spin-off Consumer Healthcare Business By Mid-2022
LPNEWS

Glaxosmithkline To Spin-off Consumer Healthcare Business By Mid-2022

by forbes.com posted 1week ago 26 views
The company operates in three major business segments, Pharmaceuticals, Vaccines and Consumer Healthcare. : On June 23, 2021, GlaxoSmithKline plc (NYSE: GSK, $40.45, Market Cap: $101.8 billion) announced that it plans to spin-off its Consumer Healthcare division into a separately listed company. The company operates in three major business segments, Pharmaceuticals, Vaccines and Consumer Healthcare. Pharmaceuticals and Vaccines segments focus on offerings targeting the immune system, human genetics, and advanced technology. The Consumer Healthcare business comprises major brands targeting oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.

In this article